MyGeneRank: A Digital Platform for Next-Generation Genetic Studies

Plain-language summary

This study evaluates MyGeneRank, a digital platform that provides participants with genetic risk information based on their own genetic data. It can include people over 18 who are willing to share their 23andMe data and who use an Apple mobile device. It is a non-phase study that is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Recruiting

Sponsor

Scripps Translational Science Institute

Intervention

Receive genetic risk information

Start date

9/26/2017

Estimated completion

9/1/2030

Countries

United States

Related genes

Locations

• La Jolla, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Customer of 23andMe willing to share their 23andMe data
* User of Apple mobile device

Exclusion Criteria:

* Under 18 years old